Literature DB >> 22436790

A research agenda for radiation oncology: results of the radiation oncology institute's comprehensive research needs assessment.

Reshma Jagsi1, Justin E Bekelman, Otis W Brawley, Joseph O Deasy, Quynh-Thu Le, Jeff M Michalski, Benjamin Movsas, Charles R Thomas, Colleen A Lawton, Theodore S Lawrence, Stephen M Hahn.   

Abstract

PURPOSE: To promote the rational use of scarce research funding, scholars have developed methods for the systematic identification and prioritization of health research needs. The Radiation Oncology Institute commissioned an independent, comprehensive assessment of research needs for the advancement of radiation oncology care. METHODS AND MATERIALS: The research needs assessment used a mixed-method, qualitative and quantitative social scientific approach, including structured interviews with diverse stakeholders, focus groups, surveys of American Society for Radiation Oncology (ASTRO) members, and a prioritization exercise using a modified Delphi technique.
RESULTS: Six co-equal priorities were identified: (1) Identify and develop communication strategies to help patients and others better understand radiation therapy; (2) Establish a set of quality indicators for major radiation oncology procedures and evaluate their use in radiation oncology delivery; (3) Identify best practices for the management of radiation toxicity and issues in cancer survivorship; (4) Conduct comparative effectiveness studies related to radiation therapy that consider clinical benefit, toxicity (including quality of life), and other outcomes; (5) Assess the value of radiation therapy; and (6) Develop a radiation oncology registry.
CONCLUSIONS: To our knowledge, this prioritization exercise is the only comprehensive and methodologically rigorous assessment of research needs in the field of radiation oncology. Broad dissemination of these findings is critical to maximally leverage the impact of this work, particularly because grant funding decisions are often made by committees on which highly specialized disciplines such as radiation oncology are not well represented.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22436790     DOI: 10.1016/j.ijrobp.2011.11.076

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Demonstration of a software design and statistical analysis methodology with application to patient outcomes data sets.

Authors:  Charles Mayo; Steve Conners; Christopher Warren; Robert Miller; Laurence Court; Richard Popple
Journal:  Med Phys       Date:  2013-11       Impact factor: 4.071

Review 2.  Evolution of advanced technologies in prostate cancer radiotherapy.

Authors:  Nicholas G Zaorsky; Amy S Harrison; Edouard J Trabulsi; Leonard G Gomella; Timothy N Showalter; Mark D Hurwitz; Adam P Dicker; Robert B Den
Journal:  Nat Rev Urol       Date:  2013-09-10       Impact factor: 14.432

3.  Opportunities to reduce cancer barriers: community town halls and provider focus groups.

Authors:  Maghboeba Mosavel; Carlin Rafie; Debbie L Cadet; Antoinette Ayers
Journal:  J Cancer Educ       Date:  2012-12       Impact factor: 2.037

4.  Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis.

Authors:  Kelsey L Corrigan; Brian De; Michael K Rooney; Ethan B Ludmir; Prajnan Das; Grace L Smith; Cullen M Taniguchi; Bruce D Minsky; Eugene J Koay; Albert C Koong; Emma B Holliday
Journal:  Adv Radiat Oncol       Date:  2022-04-30

5.  A prospective cohort study of patient-reported vomiting, retching, nausea and antiemetic use during neoadjuvant long-course radiation therapy and concurrent 5-fluorouracil-based chemotherapy for rectal adenocarcinoma.

Authors:  Kristopher Dennis; Liang Zeng; Carlo De Angelis; Hans Chung; Natalie Coburn; Edward Chow; C Shun Wong
Journal:  Clin Transl Radiat Oncol       Date:  2018-04-05

6.  Diffusion of innovation in radiation oncology in the United States.

Authors:  Patricia Sansourekidou; Vasileios Margaritis; Wen-Hung Kuo
Journal:  BJR Open       Date:  2020-08-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.